Niva Bupa Health Insurance Company (NIVABUPA) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
20 Nov, 2025Executive summary
Unaudited financial results for the quarter ended June 30, 2025, were reviewed and approved by the Board and auditors, with an unmodified conclusion issued.
Gross premiums written grew 11.46% year-over-year to ₹163,190 lakhs, with net premium written at ₹128,787 lakhs.
The company reported a net loss after tax of ₹9,144 lakhs for the quarter, compared to a net loss of ₹1,882 lakhs in the same quarter last year.
IPO proceeds of ₹80,000 lakhs were largely utilized, with ₹477 lakhs remaining unutilized as of June 30, 2025.
Financial highlights
Net premium earned was ₹122,000 lakhs, and total income stood at ₹130,842 lakhs for the quarter.
Underwriting loss was ₹23,364 lakhs, and operating loss was ₹14,522 lakhs.
Net worth as of June 30, 2025, was ₹298,761 lakhs.
Basic and diluted EPS for the quarter were both negative at (₹0.50).
Outlook and guidance
The company is working with IRDAI to bring Expenses of Management (EOM) within prescribed limits by FY 2025-26, with forbearance application pending.
Financial results for the quarter are not indicative of full-year performance due to industry seasonality.
Latest events from Niva Bupa Health Insurance Company
- Premiums and profits surged, solvency strong, retail health share up, IPO completed.NIVABUPA
Q3 24/253 Feb 2026 - PAT up 74% YoY to INR 208 crore; GWP up 25.9%; solvency strong at 2.49.NIVABUPA
Q3 25/263 Feb 2026 - Premiums up over 33%, IFRS profit doubled, but Q2 FY26 saw a net loss amid regulatory changes.NIVABUPA
Q2 24/2512 Jan 2026 - GWP up 32%, PAT up 161%, retail share at 9.4%, AUM at INR 8,175 crores, EOM action ongoing.NIVABUPA
Q4 24/256 Jan 2026 - GWP up 28% YoY, IFRS PAT doubled, and combined ratio improved under IFRS.NIVABUPA
Q1 25/266 Jan 2026 - H1 FY26 saw 23% GWP growth, doubled PAT, and GST cut drove a surge in retail demand.NIVABUPA
Q2 25/2613 Nov 2025